Unichem Laboratories Completes Phase I Capacity Expansion of API Plant

Unichem Laboratories Limited has completed the Phase I capacity expansion of its Active Pharmaceutical Ingredient (API) plant. This strategic move is part of Unichem's broader plan to enhance its API manufacturing capabilities, supporting both domestic and international markets. The company has been focusing on expanding its API production to reduce dependence on imports and capitalize on the growing demand for high-quality APIs globally. With this expansion, Unichem aims to strengthen its position in the pharmaceutical industry by leveraging its backward integration capabilities and improving operational efficiency. The company's API facilities are designed to meet stringent regulatory standards, ensuring compliance with major global authorities.

Source: Reuters, Unichem Laboratories Limited, Medical Dialogues